Certified by Founder Lodge
Sionna Therapeutics
United States - Boston, MA
START UP
1 Disclosed Funding Rounds $182,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecul
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 07 ,2024 | Series C | $182,000,000 |
Atlas Venture
Viking Global Investors
RA Capital Management, L.P.
T. Rowe Price
Enavate Sciences
Perceptive Advisors
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)